Characteristic
|
OR (95% CI)
|
p-value
|
aOR (95% CI)b
|
p-value
|
Maternal characteristics
|
Age (years)
| |
0.95 (0.89–1.02)
|
0.137
| | |
Unmarried/not cohabiting
|
1.56 (0.33–7.41)
|
0.572
| | |
Duration of relationship (years)
|
0.91 (0.84–0.98)
|
0.017*
|
0.90 (0.82–0.98)
|
0.015*
|
Education
|
None
|
ref
| | | |
|
Primary
|
1.31 (0.40–4.30)
|
0.653
| | |
|
Secondary
|
1.63 (0.46–5.78)
|
0.447
| | |
|
> Secondary
|
1.67 (1.41–6.74)
|
0.470
| | |
Employment
|
Salaried
|
ref
| |
ref
| |
Self employed
|
4.18 (0.49–35.51)
|
0.188
|
4.11 (0.47–35.77)
|
0.198
|
Housewife
|
5.67 (0.71–45.23)
|
0.100
|
5.07 (0.65–39.52)
|
0.120
|
Unemployed
|
10.47 (1.20–91.31)
|
0.034*
|
9.19 (1.06–79.41)
|
0.044
|
KSH ≤ 5000 income/month
|
0.61 (0.26–1.47)
|
0.269
| | |
IPV (from current male partner)c
|
1.08 (0.49–2.38)
|
0.853
| | |
Current male partner characteristics
|
Partner age (years)
|
0.97 (0.92–1.02)
|
0.209
| | |
Partner education
|
None
|
ref
| | | |
Primary
|
0.29 (0.08–1.03)
|
0.056
| | |
Secondary
|
0.40 (0.11–1.45)
|
0.163
| | |
> Secondary
|
0.44 (0.10–2.03)
|
0.290
| | |
Partner employment
|
Unemployed
|
ref
| |
ref
| |
Self employed
|
0.59 (0.28–1.25)
|
0.165
|
0.61 (0.30–1.24)
|
0.169
|
Salaried
|
0.43 (0.20–0.93)
|
0.033*
|
0.42 (0.18–0.96)
|
0.039
|
Partner tested for HIV
| |
0.69 (0.26–1.81)
|
0.445
| | |
Partner HIV statusd
|
HIV-uninfected
|
ref
| | | |
|
HIV-infected
|
0.46 (0.17–1.24)
|
0.124
| | |
|
Unknown
|
–
| | | |
Obstetric history
|
Number of living children
|
0.89 (0.69–1.16)
|
0.405
| | |
≥4 ANC visitse
|
0.65 (0.37–1.15)
|
0.139
| | |
Partner did not attend ANCe
|
2.65 (1.29–5.43)
|
0.009*
|
2.62 (1.28–5.35)
|
0.009*
|
Health facility deliverye
|
1.10 (0.48–2.54)
|
0.823
| | |
HIV-related characteristics
|
CD4 testing uptake
|
0.29 (0.14–0.59)
|
0.001*
|
0.32 (0.15–0.69)
|
0.004
|
CD4 results received
|
0.49 (0.22–1.10)
|
0.084
| | |
Currently on HAART for own health
|
0.39 (0.21–0.74)
|
0.005*
|
0.51 (0.25–1.04)
|
0.063
|
Maternal ARV use
|
During pregnancy
|
0.42 (0.16–1.10)
|
0.078
| | |
During labour
|
0.25 (0.11–0.53)
|
< 0.001*
|
0.38 (0.15–0.97)
|
0.042
|
During breastfeeding
|
0.30 (0.15–0.62)
|
< 0.001*
|
0.50 (0.22–1.14)
|
0.096
|
Infant received PCR testing
|
0.56 (0.31–1.01)
|
0.053*
|
0.60 (0.32–1.09)
|
0.093
|
Infant ARV use
|
0.08 (0.03–0.22)
|
< 0.001*
|
0.08 (0.02–0.31)
|
< 0.001
|